Implementation of guidelines for implantable cardioverter-defibrillator therapy in clinical practice: Which patients do benefit?
about
Managing patients with advisory defibrillator leads: what can we learn from published data?ICDs at higher age and clinical risk factors.Patient perspective on remote monitoring of cardiovascular implantable electronic devices: rationale and design of the REMOTE-CIED studyFollow-up of implantable cardioverter-defibrillator therapy: comparison of coronary artery disease and dilated cardiomyopathy.Improvement in CRT: new strategies, better choices.Gender Differences in Appropriate Shocks and Mortality among Patients with Primary Prophylactic Implantable Cardioverter-Defibrillators: Systematic Review and Meta-AnalysisThe risk of ventricular arrhythmias in a Dutch CRT population: CRT-defibrillator versus CRT-pacemakerSex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators.The patient perspective on remote monitoring of patients with an implantable cardioverter defibrillator: Narrative review and future directions.State of the art of ICD programming: Lessons learned and future directions.Who benefits from implantable cardioverter defibrillator therapy, and who pays the price?Diagnostic tests to predict outcome in patients with implantable cardioverter defibrillators: it is not that simple!Predictors of mortality and ICD shock therapy in primary prophylactic ICD patients-A systematic review and meta-analysis.Prognostic value of microvolt T-wave alternans in a real-world ICD population. Twente ICD Cohort Studie (TICS).ESC Congress 2015, London: hot lines truly hot?Driving restrictions for Dutch patients with an implantable cardioverter defibrillator : Compliance and associated factors.
P2860
Q30934904-6719D501-0C43-4A47-8BE8-F618EFBE888DQ33651346-56635828-B0B0-4B4D-8A1E-0086A2612B7DQ34302781-D0B28330-A7C8-4A67-8388-7D4CE62D7CE2Q34302789-B42C279A-2144-4091-AC1C-C4149C82A6E9Q34302795-FDE499E3-5DCB-4555-A5BF-38F9FD42B2EBQ36130094-F27B822B-E640-40A5-9994-31C53DA0AEA3Q36632192-96F030AF-B86F-4A2B-9474-117051815E26Q37153927-70E811C1-DD62-43A2-8B6D-5D071E45008AQ38671196-AB846515-9910-429F-BD7E-FE73A0520E47Q39151682-75464933-C7ED-4C9C-819D-B2D2C0F8E871Q40953694-DC9E17B7-869C-48B1-9010-B509E36BF0BDQ42155207-97D92BA0-E4D3-4B60-AFBE-FAEDF6F7CA5DQ42685181-47356579-7EF3-4468-9332-B70B758BDC37Q42934075-673AA8EC-D245-4FA3-B4B5-111664FA604EQ43216119-878ED284-3231-42AC-ADC5-ECC87C3FC24CQ47278874-0AC5F558-412A-49D4-96E7-DB0E3569F8D7
P2860
Implementation of guidelines for implantable cardioverter-defibrillator therapy in clinical practice: Which patients do benefit?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Implementation of guidelines f ...... ce: Which patients do benefit?
@en
type
label
Implementation of guidelines f ...... ce: Which patients do benefit?
@en
prefLabel
Implementation of guidelines f ...... ce: Which patients do benefit?
@en
P2093
P2860
P1476
Implementation of guidelines f ...... ce: Which patients do benefit?
@en
P2093
A E Tuinenburg
B Y M van der Kolk
P A F Doevendans
S C Wijers
P2860
P2888
P304
P356
10.1007/S12471-013-0407-X
P577
2013-06-01T00:00:00Z